These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35688053)

  • 1. Outcomes of patients treated with low-dose flumazenil for benzodiazepine detoxification: A description of 26 participants.
    MacDonald T; Gallo AT; Basso-Hulse G; Hulse GK
    Drug Alcohol Depend; 2022 Aug; 237():109517. PubMed ID: 35688053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine dependence and its treatment with low dose flumazenil.
    Hood SD; Norman A; Hince DA; Melichar JK; Hulse GK
    Br J Clin Pharmacol; 2014 Feb; 77(2):285-94. PubMed ID: 23126253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind randomised crossover trial of low-dose flumazenil for benzodiazepine withdrawal: A proof of concept.
    MacDonald T; Gallo AT; Basso-Hulse G; Bennett KS; Hulse GK
    Drug Alcohol Depend; 2022 Jul; 236():109501. PubMed ID: 35644071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.
    Moore PW; Donovan JW; Burkhart KK; Waskin JA; Hieger MA; Adkins AR; Wert Y; Haggerty DA; Rasimas JJ
    J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow subcutaneous infusion of flumazenil for the treatment of long-term, high-dose benzodiazepine users: a review of 214 cases.
    Faccini M; Leone R; Opri S; Casari R; Resentera C; Morbioli L; Conforti A; Lugoboni F
    J Psychopharmacol; 2016 Oct; 30(10):1047-53. PubMed ID: 27166362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: a case series.
    Hulse G; O'Neil G; Morris N; Bennett K; Norman A; Hood S
    J Psychopharmacol; 2013 Feb; 27(2):222-7. PubMed ID: 22596209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precipitated abstinence in orally dosed benzodiazepine-dependent dogs.
    Martin WR; Sloan JW; Wala E
    J Pharmacol Exp Ther; 1990 Nov; 255(2):744-55. PubMed ID: 1978731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of flumazenil in the treatment of benzodiazepine withdrawal--a double-blind pilot study.
    Saxon L; Hjemdahl P; Hiltunen AJ; Borg S
    Psychopharmacology (Berl); 1997 May; 131(2):153-60. PubMed ID: 9201803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users.
    Mintzer MZ; Stoller KB; Griffiths RR
    Psychopharmacology (Berl); 1999 Nov; 147(2):200-9. PubMed ID: 10591888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The problems of long-term treatment with benzodiazepines and related substances.
    Janhsen K; Roser P; Hoffmann K
    Dtsch Arztebl Int; 2015 Jan; 112(1-2):1-7. PubMed ID: 25613443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data.
    Gallo AT; Hulse G
    J Psychopharmacol; 2021 Mar; 35(3):211-220. PubMed ID: 33426982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose benzodiazepine dependence: description of 29 patients treated with flumazenil infusion and stabilised with clonazepam.
    Quaglio G; Pattaro C; Gerra G; Mathewson S; Verbanck P; Des Jarlais DC; Lugoboni F
    Psychiatry Res; 2012 Aug; 198(3):457-62. PubMed ID: 22424905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in relative potency among positive GABA(A) receptor modulators upon discontinuation of chronic benzodiazepine treatment in rhesus monkeys.
    McMahon LR; Javors MA; France CP
    Psychopharmacology (Berl); 2007 May; 192(1):135-45. PubMed ID: 17245585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles.
    Hood S; O'Neil G; Hulse G
    J Psychopharmacol; 2009 Jun; 23(4):401-9. PubMed ID: 19164495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of aggression during benzodiazepine withdrawal: effects of flumazenil.
    Saxon L; Borg S; Hiltunen AJ
    Pharmacol Biochem Behav; 2010 Aug; 96(2):148-51. PubMed ID: 20451546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo absence status epilepticus as a benzodiazepine withdrawal syndrome.
    Thomas P; Lebrun C; Chatel M
    Epilepsia; 1993; 34(2):355-8. PubMed ID: 8384109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benzodiazepine withdrawal in subjects on opiate substitution treatment].
    Fatséas M; Lavie E; Denis C; Franques-Rénéric P; Tignol J; Auriacombe M
    Presse Med; 2006 Apr; 35(4 Pt 1):599-606. PubMed ID: 16614601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.
    McGregor C; Machin A; White JM
    Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flumazenil: a possible treatment for benzodiazepine withdrawal anxiety.
    File SE; Baldwin HA
    Lancet; 1987 Jul; 2(8550):106-7. PubMed ID: 2885562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.